Advertisement

Volume Replacement

  • Jean-Francois Baron
  • Johannes Treib

Table of contents

About these proceedings

Introduction

Because of their therapeutic safety, hydroxyethylstarch, gelatin and dextrans are among the most frequently used drugs in the world. Recent studies have shown that bleeding disorders, anaphylactic reactions and storage in the body depend decisively on the nature of the administered plasma substitute. Through interdisciplinary cooperation the "First European Volume Replacement Conference" has established indications for the use of individual plasma substitutes to improve the efficacy and therapeutic safety of volume replacement therapy.

Keywords

Blutersatzstoffe Trauma Volume Replacement aextrans complications gelatins oxygen carriers plasma plasma volume support shock surgery

Editors and affiliations

  • Jean-Francois Baron
    • 1
  • Johannes Treib
    • 2
  1. 1.Anesthesie-ReanimationUniversité Pierre et Marie Curie Paris VIParisFrance
  2. 2.Neurologische KlinikUniversitätskliniken des SaarlandesHomburg/SaarGermany

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-642-72170-0
  • Copyright Information Springer-Verlag Berlin Heidelberg 1998
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-540-64187-2
  • Online ISBN 978-3-642-72170-0
  • Buy this book on publisher's site
Industry Sectors
Pharma
Biotechnology